Pirprofen in acute ocular inflammation: a controlled study.

Area of Science:

• Ophthalmology
• Pharmacology
• Clinical Medicine

Background:

• Acute ocular inflammation presents a significant clinical challenge.
• Effective anti-inflammatory treatments are crucial for managing ocular conditions.
• Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for their anti-inflammatory properties.

Purpose of the Study:

• To compare the efficacy and tolerability of pirprofen versus indomethacin in treating acute ocular inflammation.
• To evaluate the impact of these treatments on specific ocular inflammatory markers and pain.

Main Methods:

• A double-blind, between-patient clinical trial involving 30 patients with acute ocular inflammation.
• Patients received either pirprofen (400 mg twice daily) or indomethacin (50 mg twice daily) for 14 days.
• Efficacy was assessed using 4-point scales for keratic injection, Tyndall phenomenon, vitreous changes, endothelial precipitates, and pain severity.

Main Results:

• Both pirprofen and indomethacin significantly improved all assessed parameters of ocular inflammation and pain.
• Non-parametric statistical tests confirmed the significant efficacy of both treatments.
• Both drugs were generally well tolerated, with one patient discontinuing pirprofen due to gastralgia.

Conclusions:

• Pirprofen and indomethacin are effective treatments for acute ocular inflammation.
• Both medications demonstrate comparable efficacy and favorable tolerability profiles.
• Further research may explore long-term outcomes and specific patient populations.